Medication-Assisted Treatment (MAT) for opioid addiction is available through the Office-Based Opioid Treatment (OBOT) program at all BCCS Treatment Centers in Delaware. Everyone who presents is seen by staff, and same day support services are available to all.
Our Office-Based Opioid Treatment (OBOT) utilizes Suboxone (buprenorphine and naloxone) and Subutex (buprenorphine) and is designed for individuals with opioid use disorder who – considering psychosocial factors, treatment history, and other indicators – may benefit from buprenorphine treatment and are able to safely and effectively manage and self-administer prescription medications at home. OBOT clients also participate in regular counseling sessions.
In the Medication-Assisted Treatment (MAT) model, medication is used in combination with counseling and behavioral therapies. Medications can reduce the cravings and other symptoms associated with withdrawal from a substance by occupying receptors in the brain associated with using that drug (agonists or partial agonists), blocking the rewarding sensation that comes with using a substance (antagonists), or inducing negative feelings when a substance is taken.
Opioid agonist therapies with methadone or buprenorphine reduce the effects of opioid withdrawal, reduce cravings, and reduce the risk of relapse, and have also been shown to increase retention in treatment and reduce high-risk behaviors that lead to transmission of HIV and viral hepatitis, such as using opioids by injection.
Be the first to comment on "OBOT | Office-Based Opioid Treatment"